Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 Feb;27(2):230–237.

The spectrum of human tuberculosis.

L Lenzini, P Rottoli, L Rottoli
PMCID: PMC1540785  PMID: 849655

Abstract

Clinical, morphological and immunological studies of human tuberculosis have enabled the spectrum of the disease to be determined. We have investigated the cell-mediated immune responses by means of skin tests and leucocyte migration inhibition to PPD, and the humoral immune responses by means of immunodiffusion and haemagglutination tests. Patients with tuberculosis can be classified into two polar groups--reactive (RR) and unreactive (UU), the former showing good cell-mediated immunity and little or no antibody formation and the latter poor cellular responses and exuberant antibody production. The intermediate forms show characteristics of the neighbouring polar groups. The existence of a spectrum of immune response in tuberculosis, which has long been suspected, is now demonstrated.

Full text

PDF
232

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brostoff J. Migration inhibition studies in human disease. Proc R Soc Med. 1970 Sep;63(9):905–906. [PMC free article] [PubMed] [Google Scholar]
  2. Lefford M. J., McGregor D. D., Mackaness G. B. Immune response to Mycobacterium tuberculosis in rats. Infect Immun. 1973 Aug;8(2):182–189. doi: 10.1128/iai.8.2.182-189.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Lenzini L., Barnabé R. The nature of changes in the cellular infiltration during two weeks after tuberculin testing in patients with active tuberculosis. Int Arch Allergy Appl Immunol. 1969;35(4):402–410. doi: 10.1159/000230192. [DOI] [PubMed] [Google Scholar]
  4. Lenzini L., Rottoli L., Rottoli P. Inbizione della migrazione leucocitaria nella tubercolosi e in malattie con anergia cutanea. Ann Sclavo. 1974 Jan-Feb;16(1):29–56. [PubMed] [Google Scholar]
  5. Lenzini L., Rottoli P., Rottoli L., Sestini S. Gli anticopri circolanti liberi anti PPD nell'infezione e nella malattia tubercolare. Boll Soc Ital Biol Sper. 1974 Feb 15;50(3):89–93. [PubMed] [Google Scholar]
  6. Mackaness G. B. The immunology of antituberculous immunity. Am Rev Respir Dis. 1968 Mar;97(3):337–344. doi: 10.1164/arrd.1968.97.3.337. [DOI] [PubMed] [Google Scholar]
  7. North R. J. Importance of thymus-derived lymphocytes in cell-mediated immunity to infection. Cell Immunol. 1973 Apr;7(1):166–176. doi: 10.1016/0008-8749(73)90193-7. [DOI] [PubMed] [Google Scholar]
  8. Turk J. L., Bryceson A. D. Immunological phenomena in leprosy and related diseases. Adv Immunol. 1971;13:209–266. doi: 10.1016/s0065-2776(08)60185-6. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES